Postdose 3 G1 serum neutralizing antibody as correlate of protection for pentavalent rotavirus vaccine
Although clinical trials of the pentavalent rotavirus vaccine (RotaTeq®, RV5) have demonstrated efficacy against RV gastroenteritis (RGE) in low and high-income settings, a clear correlate of protection or a measure of immune response that could predict efficacy has yet to be identified. This is the...
Main Authors: | G. Frank Liu, Darcy Hille, Susan S. Kaplan, Michelle G. Goveia |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2017-10-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2017.1356522 |
Similar Items
-
A phase 3 randomized, open-label study evaluating the immunogenicity and safety of concomitant and staggered administration of a live, pentavalent rotavirus vaccine and an inactivated poliomyelitis vaccine in healthy infants in China
by: Shaomin Chen, et al.
Published: (2024-12-01) -
Meta-analysis of the effectiveness of pentavalent live oral vaccine for the prevention of severe forms of rotavirus gastroenteritis in children
by: A. A. Kosova, et al.
Published: (2020-11-01) -
Concomitant administration of diphtheria, tetanus, acellular pertussis and inactivated poliovirus vaccine derived from Sabin strains (DTaP-sIPV) with pentavalent rotavirus vaccine in Japanese infants
by: Yoshiyuki Tanaka, et al.
Published: (2017-06-01) -
Reactogenicity, safety and immunological efficacy of the live, pentavalent rotavirus vaccine in childhood immunization (results of the multicenter clinical trial)
by: Irina V. Feldblium, et al.
Published: (2020-09-01) -
Effectiveness and Safety of Bovine Human Pentavalent Rotavirus Vaccine (BRV-PV) in Preventing Severe Acute Rotavirus Gastroenteritis (SRVGE): A systematic review of the experience in developing countries
by: Zefianto, et al.
Published: (2024-02-01)